Clinical course of neuropathologically confirmed frontal-variant Alzheimer's disease

[1]  M. Spillantini,et al.  Frontotemporal Dementia with Tau Pathology , 2007, Neurodegenerative Diseases.

[2]  N. Hitzeman.  Cholinesterase inhibitors for Alzheimer's disease. , 2006, American family physician.

[3]  M. Mendez,et al.  Frontotemporal Dementia-like Phenotypes Associated With Presenilin-1 Mutations , 2006, American journal of Alzheimer's disease and other dementias.

[4]  L. Fratiglioni,et al.  Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.

[5]  Jordan Grafman,et al.  A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia , 2006, Neurology.

[6]  John Hodges,et al.  Pathologically proven frontotemporal dementia presenting with severe amnesia. , 2005, Brain : a journal of neurology.

[7]  B. Sahakian,et al.  Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial , 2004, Psychopharmacology.

[8]  B Miller,et al.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. , 2001, Archives of neurology.

[9]  D. Neary,et al.  Distinct behavioural profiles in frontotemporal dementia and semantic dementia , 2001, Journal of neurology, neurosurgery, and psychiatry.

[10]  K. Patterson,et al.  Severe Anterograde Amnesia with Extensive Hippocampal Degeneration in a Case of Rapidly Progressive Frontotemporal Dementia. , 2001, Neurocase.

[11]  C. Cotman,et al.  Clinical and pathological evidence for a frontal variant of Alzheimer disease. , 1999, Archives of neurology.

[12]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[13]  M. Freedman,et al.  Frontotemporal lobar degeneration , 1998, Neurology.

[14]  K. Davis.  Cholinesterase Inhibitors in Alzheimer's Disease , 1994, Neuropsychopharmacology.

[15]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[16]  F. Sherriff,et al.  Memantine for dementia. , 2005, The Cochrane database of systematic reviews.